Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,103Revenue (TTM) $M14,563Net Margin (%)4.9Altman Z-Score2.1
Enterprise Value $M20,792EPS (TTM) $3.5Operating Margin %12.1Piotroski F-Score7
P/E(ttm)19.0Beneish M-Score-2.7Pre-tax Margin (%)9.3Higher ROA y-yY
Price/Book2.710-y EBITDA Growth Rate %11.7Quick Ratio1.5Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %9.5Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow12.7y-y EBITDA Growth Rate %30.4ROA % (ttm)3.8Higher Current Ratio y-yN
Dividend Yield %--PEG2.0ROE % (ttm)14.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M197ROIC % (ttm)8.7Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAJoel Greenblatt 2016-09-30 Buy 0.04%$63.34 - $78.44
($70.4)
$ 66.38-6%New holding45,595
DVAArnold Van Den Berg 2016-09-30 Reduce-0.03%$63.34 - $78.44
($70.4)
$ 66.38-6%Reduce -2.54%77,285
DVAMario Gabelli 2016-09-30 Reduce$63.34 - $78.44
($70.4)
$ 66.38-6%Reduce -19.20%32,613
DVAArnold Van Den Berg 2016-06-30 Reduce-3.14%$73.03 - $77.93
($75.54)
$ 66.38-12%Reduce -75.89%79,300
DVAJoel Greenblatt 2016-06-30 Sold Out -0.42%$73.03 - $77.93
($75.54)
$ 66.38-12%Sold Out0
DVAMario Gabelli 2016-06-30 Reduce$73.03 - $77.93
($75.54)
$ 66.38-12%Reduce -2.89%40,363
DVAArnold Van Den Berg 2016-03-31 Add0.76%$62.24 - $73.38
($67.47)
$ 66.38-2%Add 22.67%328,908
DVAJoel Greenblatt 2016-03-31 Add0.17%$62.24 - $73.38
($67.47)
$ 66.38-2%Add 69.62%513,100
DVAMario Gabelli 2016-03-31 Add$62.24 - $73.38
($67.47)
$ 66.38-2%Add 4.00%41,563
DVASteve Mandel 2015-12-31 Sold Out -2.41%$67.79 - $78.16
($73.23)
$ 66.38-9%Sold Out0
DVAArnold Van Den Berg 2015-12-31 Reduce-0.22%$67.79 - $78.16
($73.27)
$ 66.38-9%Reduce -6.22%268,133
DVAJoel Greenblatt 2015-12-31 Add0.19%$67.79 - $78.16
($73.23)
$ 66.38-9%Add 525.25%302,502
DVAMario Gabelli 2015-12-31 Reduce$67.79 - $78.16
($73.23)
$ 66.38-9%Reduce -4.31%39,963
DVAArnold Van Den Berg 2015-09-30 Add1.63%$70.93 - $81.14
($77.54)
$ 66.38-14%Add 85.75%285,918
DVASteve Mandel 2015-09-30 Add0.75%$70.93 - $81.14
($77.54)
$ 66.38-14%Add 45.15%7,918,998
DVAJoel Greenblatt 2015-09-30 Buy 0.03%$70.93 - $81.14
($77.54)
$ 66.38-14%New holding48,381
DVAArnold Van Den Berg 2015-06-30 Reduce-0.11%$79.47 - $84.23
($82.11)
$ 66.38-19%Reduce -5.86%153,928
DVAMario Gabelli 2015-06-30 Add$79.47 - $84.23
($82.11)
$ 66.38-19%Add 5.29%41,763
DVAArnold Van Den Berg 2015-03-31 Buy 1.87%$72.78 - $82.84
($76.74)
$ 66.38-14%New holding163,503
DVASteve Mandel 2015-03-31 Add0.47%$72.78 - $82.84
($76.74)
$ 66.38-14%Add 38.47%5,455,774
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-08-09Sell20,262$73.09-9.32view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-11Sell1,291$78.51-15.58view
JIGANTI JEANINE MARIEChief Compliance Officer 2016-07-01Sell4,620$77.45-14.42view
Arway Pamela MDirector 2016-05-25Sell10,824$77.16-14.1view
HILGER JAMES KInterim CFO and CAO 2016-05-23Sell3,416$76.79-13.69view
THIRY KENT JChairman and CEO 2016-05-20Sell32,880$76.99-13.91view
Kogod DennisPres, HCP & CEO, DVA Int. 2016-05-17Sell17,700$77.35-14.31view
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs 2016-05-17Sell538$77.08-14.01view
HILGER JAMES KInterim CFO and CAO 2016-05-16Sell3,983$75.59-12.32view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2016-05-16Sell4,934$75.69-12.43view

Press Releases about DVA :

Quarterly/Annual Reports about DVA:

News about DVA:

Articles On GuruFocus.com
Are Any of Buffett's Holdings Cheap Enough to Buy? Nov 09 2016 
3 Warren Buffett Stocks Fall to 52-Week Lows Oct 28 2016 
Baxter Well Positioned in Fast-Growing Market for Kidney Dialysis Equipment Jul 01 2016 
Arnold Van Den Berg's Largest Buys in 1st Quarter Apr 21 2016 
Weekly CEO Sells Highlights Apr 18 2016 
7 High Quality Guru Stocks Apr 11 2016 
Steve Mandel Sells Health Care Stakes Mar 11 2016 
Undervalued, Predictable Companies Include Monsanto and Western Union Mar 10 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 

More From Other Websites
South Jersey health system forms kidney care joint venture Dec 08 2016
DaVita Ties Up With Inspira Health, Expands in South Jersey Dec 05 2016
DaVita Launches Joint Venture with Inspira Health Network to Provide Dialysis Services in South... Dec 02 2016
DaVita and Rock Health Announce Partnership to Advance Innovation in Healthcare Nov 29 2016
Humana to Add JSA Medical Group’s New Primary Care Practices Designed Exclusively for Medicare... Nov 28 2016
Has The Time To Buy Davita Inc (DVA) Arrived? Nov 24 2016
ETFs with exposure to DaVita, Inc. : November 22, 2016 Nov 22 2016
DaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : November 21, 2016 Nov 21 2016
HealthCare Partners Saves $1.6 million in Anthem Blue Cross Enhanced Personal Health Care Program Nov 17 2016
HealthCare Partners Encourages Medicare Beneficiaries to Review Health Plans during Open Enrollment Nov 17 2016
DaVita Clinical Research to Present 12 Abstracts at American Society of Nephrology Kidney Week 2016 Nov 14 2016
Election 2016: Colorado voters embrace open primary elections Nov 09 2016
DAVITA INC. Financials Nov 09 2016
DaVita Supports National Diabetes Month Nov 08 2016
ETF’s with exposure to DaVita, Inc. : November 7, 2016 Nov 07 2016
DaVita, Inc. :DVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 Nov 04 2016
DaVita (DVA) Q3 Earnings Beat Estimates on Lower Expenses Nov 03 2016
Edited Transcript of DVA earnings conference call or presentation 2-Nov-16 9:00pm GMT Nov 03 2016
DaVita Inc Earnings Call scheduled for 5:00 pm ET today Nov 02 2016
DAVITA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)